Imricor Medical Systems, Inc. (ASX:IMR)

Market Cap	429.84M
Revenue (ttm)	1.24M
Net Income (ttm)	-30.37M
Shares Out	270.34M
EPS (ttm)	-0.17
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	240,021
Average Volume	244,476
Open	1.530
Previous Close	1.520
Day's Range	1.525 - 1.590
52-Week Range	0.410 - 1.590
Beta	0.20
RSI	67.28
Earnings Date	Feb 24, 2025

About Imricor Medical Systems

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company’s principal product includes the Advantage-MR EP Recorder/Stimulator system, an EP recording system and cardiac stimulator. Its products also include Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2006
• Country: United States
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IMR

Financial Performance

In 2023, Imricor Medical Systems's revenue was $615,568, a decrease of -24.56% compared to the previous year's $816,011. Losses were -$22.63 million, 30.4% more than in 2022.

Financial numbers in USD